IL177028A0 - Use of aerosolized antithrombin to treat acute lung injury - Google Patents

Use of aerosolized antithrombin to treat acute lung injury

Info

Publication number
IL177028A0
IL177028A0 IL177028A IL17702806A IL177028A0 IL 177028 A0 IL177028 A0 IL 177028A0 IL 177028 A IL177028 A IL 177028A IL 17702806 A IL17702806 A IL 17702806A IL 177028 A0 IL177028 A0 IL 177028A0
Authority
IL
Israel
Prior art keywords
lung injury
acute lung
treat acute
antithrombin
aerosolized
Prior art date
Application number
IL177028A
Other languages
English (en)
Original Assignee
Gtc Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtc Biotherapeutics Inc filed Critical Gtc Biotherapeutics Inc
Publication of IL177028A0 publication Critical patent/IL177028A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL177028A 2004-01-23 2006-07-23 Use of aerosolized antithrombin to treat acute lung injury IL177028A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53867804P 2004-01-23 2004-01-23
US11/034,590 US20050169908A1 (en) 2004-01-23 2005-01-13 Use of aerosolized antithrombin to treat acute lung injury
PCT/US2005/001238 WO2005072139A2 (en) 2004-01-23 2005-01-14 Use of aerosolized antithrombin to treat acute lung injury

Publications (1)

Publication Number Publication Date
IL177028A0 true IL177028A0 (en) 2006-12-10

Family

ID=34810485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177028A IL177028A0 (en) 2004-01-23 2006-07-23 Use of aerosolized antithrombin to treat acute lung injury

Country Status (8)

Country Link
US (1) US20050169908A1 (https=)
EP (1) EP1713500A2 (https=)
JP (1) JP4854519B2 (https=)
KR (1) KR20060127992A (https=)
AU (1) AU2005208552A1 (https=)
CA (1) CA2553758A1 (https=)
IL (1) IL177028A0 (https=)
WO (1) WO2005072139A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2480790A1 (en) * 2002-04-01 2003-10-16 Kazunori Murakami Use of antithrombin iii in treating acute lung injury
US20050192226A1 (en) * 2004-02-20 2005-09-01 Perenlei Enkhbaatar Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
US20050245444A1 (en) * 2004-04-30 2005-11-03 Yann Echelard Method of using recombinant human antithrombin for neurocognitive disorders
US20060121004A1 (en) * 2004-12-07 2006-06-08 Yann Echelard Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
ES2811526T3 (es) 2010-12-30 2021-03-12 Lab Francais Du Fractionnement Glicoles como agentes de inactivación de patógenos
WO2014089327A1 (en) * 2012-12-05 2014-06-12 National Jewish Health Treatment for airway cast obstruction
US10034921B2 (en) 2013-02-13 2018-07-31 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
EP3594230A1 (en) 2013-02-13 2020-01-15 Laboratoire Français du Fractionnement et des Biotechnologies Highly galactosylated anti-tnf-alpha antibodies and uses thereof
EP3016729B1 (fr) 2013-07-05 2020-03-25 Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme Matrice de chromatographie d'affinité
PE20160789A1 (es) 2013-11-04 2016-08-17 Univ Texas Composiciones y metodos para admistracion de una enzima a las vias respiratorias de un sujeto
WO2016118625A1 (en) * 2015-01-20 2016-07-28 Incarda Therapeutics, Inc. Unit aerosol doses for anticoagulation
WO2016179447A1 (en) * 2015-05-06 2016-11-10 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5843705A (en) * 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6063593A (en) * 1996-11-12 2000-05-16 University Of Southern California University Park Campus TGFβ1 responsive bone marrow derived cells to express a recombinant protein
US6124257A (en) * 1997-08-28 2000-09-26 Lezdey; John Method of treatment
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
CA2480790A1 (en) * 2002-04-01 2003-10-16 Kazunori Murakami Use of antithrombin iii in treating acute lung injury
US20050192226A1 (en) * 2004-02-20 2005-09-01 Perenlei Enkhbaatar Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants

Also Published As

Publication number Publication date
AU2005208552A1 (en) 2005-08-11
EP1713500A2 (en) 2006-10-25
WO2005072139A2 (en) 2005-08-11
JP2007518801A (ja) 2007-07-12
WO2005072139A3 (en) 2006-01-05
CA2553758A1 (en) 2005-08-11
JP4854519B2 (ja) 2012-01-18
KR20060127992A (ko) 2006-12-13
US20050169908A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
IL169602A0 (en) Methods of treating lung diseases
GB2453188B (en) Use of compounds in the manufacture of medicaments for treatment of regional fat deposits
IL177028A0 (en) Use of aerosolized antithrombin to treat acute lung injury
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
PT2546253E (pt) Di-hidropirazolonas substituídas para o tratamento de doenças cardiovasculares e hematológicas
PT2170848E (pt) Derivados da pirazinona e sua utilização no tratamento de doenças pulmonares
GB2410919B (en) Improvements in or relating to the treatment of waste
ZA200709520B (en) Use of TFPI to treat severe bacterial infections
GB0410399D0 (en) The treatment of respiratory disease
SI2422786T1 (sl) Nove farmacevtske kombinacije za zdravljenje respiratornih obolenj
ZA200609967B (en) Treating respiratory diseases with glycopyrrolate and analogues
NO20054767D0 (no) Sammensetninger omfattende apomorfin for inhalering i lunge
IL180675A0 (en) Methods of treating ccr2 mediated diseases or disorsers
WO2009006246A8 (en) Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
ZA200609141B (en) Compositions for Inhalation therapy and methods of use
EP1737475A4 (en) VEGETABLE THERAPY FOR THE TREATMENT OF ASTHMA
SG113539A1 (en) He treatment to improve low-k adhesion property
PL1656949T3 (pl) Zastosowanie alfa-1 antytrypsyny do wytwarzania leków do leczenia fibromialgii
IL172528A0 (en) Surface treatment of sars-infected lungs
EP1871404A4 (en) ANTI-ASTHMATIC TREATMENT
IL155737A0 (en) Enriched air for treating lung diseases
GB0612748D0 (en) Treatment and/or prevention of inflammatory lung disease
GB0422611D0 (en) Treatment of cough by inhalation therapy
GB0425804D0 (en) Treatment of cough by inhalation therapy
SG123646A1 (en) Prevention of respiratory infections in fowl